ReviewVaccines2022
Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19.
Jialu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewVaccines2022
Jialu Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.